Photo of Editor Christos S. Mantzoros

Dear Friends and Colleagues,

As Editor-in-Chief of Metabolism: Clinical and Experimental, I'm happy to share great news about the journal.

Our Impact Factor has been continuously increasing over the past eleven years that I have been serving at the helm, and is now at 13.934, placing the journal amongst the top 4% of endocrinology, diabetes, and metabolism journals as indexed in Journal Citation Reports*.

This could not have happened without the dedication and expertise of the journal’s Editorial Board members as well its many reviewers and authors, to whom we are particularly thankful.

We are now committed to not only publishing findings that advance metabolism and studies on mechanisms underlying human metabolism but also to attracting and publishing high-quality clinical trials and translational research studies. Such papers should report novel diagnostic methods, novel medical therapies, clinically relevant pathways and/or other major advances in the context of either interventional or observational studies in humans, that have the distinct potential to change how we diagnose and/or treat our suffering fellow human beings.

As we continue to improve and grow, I hope that you will continue to be an integral part of our scientific family by submitting your best manuscripts for consideration, by helping us review and improve papers submitted to us and by reading and disseminating the information we publish.

We look forward to your continued productive participation in our scientific family.

With best regards,

Christos S. Mantzoros, MD, DSc, PhD h.c. mult.
Professor, Harvard Medical School

*© 2022 Journal Citation Reports® (Clarivate Analytics, 2021)